Neuroimaging Platform Uses 3D AI to Offer Brain Visualization
By MedImaging International staff writers Posted on 06 Dec 2017 |
Image: The QMENTA platform is designed to help investigators and doctors worldwide to aggregate and analyze thousands of imaging records all in one place (Photo courtesy of QMENTA).
QMENTA (Boston, MA, USA), a medical image storage, processing and visualization company focused on brain data analysis, specifically using MRI and related clinical data, has developed a cloud-based system for neuroimages and all related data, with data management, analysis and visualization capabilities.
QMENTA provides state-of-the-art medical image processing algorithms in a seamless way in order to accelerate the development of new therapies for neurological diseases via a scalable and collaborative cloud platform. The company’s purpose is to organize and quantify brain-imaging information, through complex imaging tools in a seamless manner. It aims to change the way patients are diagnosed and monitored, and disease progression and drug efficacy are measured.
The QMENTA platform has been created to help investigators and doctors worldwide to aggregate and analyze thousands of imaging records all in one place. The company’s clients upload their data (DICOM, NIfTI, etc.) to the QMENTA platform via easy drag & drop. The cloud platform facilitates efficient data and project management by allowing investigators and doctors to combine data from various sources and sites in the same place with easy query and search functionality. Both data and results can be easily shared between specialists through the cloud for enhanced collaboration.
All the data on the platform can be analyzed with one-click using state-of-the art pipelines on the cloud, eliminating hassles dealing with scripts, version control, reproducibility and many other complications, saving valuable time and resources. These customizable and flexible pipelines enable investigators to extract valuable, quantitative information from medical images. All data can be visualized in 2D or 3D (and touchless) using an integrated desktop visualization app.
QMENTA’s analytics support the discovery of new biomarkers for diagnostics by allowing investigators to easily explore correlations between changes in neuroanatomy and neurophysiology. This facilitates early and accurate diagnosis for neurological diseases and improves patient selection for clinical trials. The company aims to provide the cloud-based platform for experts, hospitals, research centers, and pharmaceutical companies to help optimize and accelerate their neuroimaging workflows.
Related Links:
QMENTA
QMENTA provides state-of-the-art medical image processing algorithms in a seamless way in order to accelerate the development of new therapies for neurological diseases via a scalable and collaborative cloud platform. The company’s purpose is to organize and quantify brain-imaging information, through complex imaging tools in a seamless manner. It aims to change the way patients are diagnosed and monitored, and disease progression and drug efficacy are measured.
The QMENTA platform has been created to help investigators and doctors worldwide to aggregate and analyze thousands of imaging records all in one place. The company’s clients upload their data (DICOM, NIfTI, etc.) to the QMENTA platform via easy drag & drop. The cloud platform facilitates efficient data and project management by allowing investigators and doctors to combine data from various sources and sites in the same place with easy query and search functionality. Both data and results can be easily shared between specialists through the cloud for enhanced collaboration.
All the data on the platform can be analyzed with one-click using state-of-the art pipelines on the cloud, eliminating hassles dealing with scripts, version control, reproducibility and many other complications, saving valuable time and resources. These customizable and flexible pipelines enable investigators to extract valuable, quantitative information from medical images. All data can be visualized in 2D or 3D (and touchless) using an integrated desktop visualization app.
QMENTA’s analytics support the discovery of new biomarkers for diagnostics by allowing investigators to easily explore correlations between changes in neuroanatomy and neurophysiology. This facilitates early and accurate diagnosis for neurological diseases and improves patient selection for clinical trials. The company aims to provide the cloud-based platform for experts, hospitals, research centers, and pharmaceutical companies to help optimize and accelerate their neuroimaging workflows.
Related Links:
QMENTA
Latest Industry News News
- Hologic Acquires UK-Based Breast Surgical Guidance Company Endomagnetics Ltd.
- Bayer and Google Partner on New AI Product for Radiologists
- Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement
- IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering
- International Societies Suggest Key Considerations for AI Radiology Tools
- Samsung's X-Ray Devices to Be Powered by Lunit AI Solutions for Advanced Chest Screening
- Canon Medical and Olympus Collaborate on Endoscopic Ultrasound Systems
- GE HealthCare Acquires AI Imaging Analysis Company MIM Software
- First Ever International Criteria Lays Foundation for Improved Diagnostic Imaging of Brain Tumors
- RSNA Unveils 10 Most Cited Radiology Studies of 2023
- RSNA 2023 Technical Exhibits to Offer Innovations in AI, 3D Printing and More
- AI Medical Imaging Products to Increase Five-Fold by 2035, Finds Study
- RSNA 2023 Technical Exhibits to Highlight Latest Medical Imaging Innovations
- AI-Powered Technologies to Aid Interpretation of X-Ray and MRI Images for Improved Disease Diagnosis
- Hologic and Bayer Partner to Improve Mammography Imaging
- Global Fixed and Mobile C-Arms Market Driven by Increasing Surgical Procedures